Application 021287

Type
NDA
Sponsor
CONCORDIA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001UROXATRALALFUZOSIN HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL10MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59212-200UroxatralAlfuzosin HClConcordia Pharmaceuticals Inc.NDACurrent
59212-200UroxatralAlfuzosin HClConcordia Pharmaceuticals Inc.NDACurrent
59212-200UroxatralAlfuzosin HClConcordia Pharmaceuticals Inc.NDACurrent
59212-200UroxatralAlfuzosin HClConcordia Pharmaceuticals Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
63319SUPPL2020-05-28
63290SUPPL2020-05-26
54235SUPPL2018-05-17
54212SUPPL2018-05-16
27392SUPPL2014-08-06
14900SUPPL2014-04-22
14899SUPPL2013-06-04
27391SUPPL2013-05-31
4930SUPPL2010-12-21
14898SUPPL2010-12-16
14897SUPPL2010-04-19
27390SUPPL2010-04-13
27389SUPPL2009-05-27
14896SUPPL2009-05-25
51200SUPPL2008-10-17
27388SUPPL2008-09-23
14895SUPPL2008-09-19
4929SUPPL2008-05-09
4928SUPPL2007-04-09
14894SUPPL2007-03-31
42083SUPPL2007-01-10
27387SUPPL2006-11-22
14893SUPPL2006-11-22
51194SUPPL2006-06-15
4927SUPPL2006-03-23
14892SUPPL2006-03-22
51193SUPPL2006-02-21
42082ORIG2003-09-09
27386SUPPL2003-07-28
27385ORIG2003-06-22
14891ORIG2003-06-22
53168SUPPL1900-01-01
53167SUPPL1900-01-01
53166SUPPL1900-01-01